Matthew Holt Insider Profile
4 Followers
Matthew Holt, Director at Avantor, holds 7.91K shares in Avantor (Ticker: AVTR), holds ― shares in R1 RCM (Ticker: RCM), holds 0.00 shares in Signify Health (Ticker: SGFY).
Matthew Holt's Trading History
| SGFYSignify Health | Mar 29, 2023 | ― | Uninformative Sell | ― | $0.00 | |
| AVTRAvantor | May 16, 2022 | Director | Uninformative Buy | ― | $122.89K | |
| BLPHBellerophon | Apr 29, 2016 | ― | Uninformative Buy | ― | $58.32K | |
| RCMR1 RCM | ― | ― | ― | ― |
You May Also Like
Matthew Holt insider profile FAQ
What is the percentage of profitable transactions made by Matthew Holt?
The percentage of profitable transactions made by Matthew Holt is 0%.
What is the average return per transaction made by Matthew Holt?
The average return per transaction made by Matthew Holt is -77.10%.
What stocks does Matthew Holt hold?
Matthew Holt holds: AVTR, RCM, BLPH, SGFY stocks.
What was Matthew Holt's most profitable transaction?
Matthew Holt’s most profitable transaction was an Informative Buy of BLPH stock on February 23, 2015. The return on the trade was -77.00%.
What is Matthew Holt's role in Avantor?
Matthew Holt's role in Avantor is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
